C.M. Bidwell & Associates’s Innoviva INVA Stock Holding History

C.M. Bidwell & Associates’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-225	Closed	-$4.52K	–	511
2025 Q2	$4.52K	Hold	225	–	–	﹤0.01%	329
2025 Q1	$4.08K	Hold	225	–	–	﹤0.01%	332
2024 Q4	$3.9K	Hold	225	–	–	﹤0.01%	367
2024 Q3	$4.34K	Hold	225	–	–	﹤0.01%	351
2024 Q2	$3.69K	Hold	225	–	–	﹤0.01%	355
2024 Q1	$3.43K	Hold	225	–	–	﹤0.01%	379
2023 Q4	$3.61K	Sell	225 -8,919	-98%	-$125K	﹤0.01%	359
2023 Q3	$119K	Hold	9,144	–	–	0.09%	194
2023 Q2	$116K	Buy	9,144 +4,924	+117%	+$61.6K	0.09%	210
2023 Q1	$47.5K	Sell	4,220 -710	-14%	-$8.62K	0.04%	300
2022 Q4	$65.3K	Buy	+4,930	New	+$64.8K	0.05%	271
2020 Q3	–	Sell	-2,055	Closed	-$29K	–	488
2020 Q2	$29K	Buy	+2,055	New	+$28K	0.03%	278

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

C.M. Bidwell & Associates's INVA Position: Q3 2025 in Review

C.M. Bidwell & Associates sold out of Innoviva (INVA) in Q3 2025, closing a stake of 225 shares — an estimated $4.52K sold.

C.M. Bidwell & Associates first reported a position in INVA in Q2 2020 and held it in 12 quarters. The position peaked at $119K in Q3 2023. 264 funds tracked by Wall St. Rank hold INVA as of Q3 2025.

C.M. Bidwell & Associates reported no remaining Innoviva position as of Q3 2025 after selling out during the quarter.
C.M. Bidwell & Associates sold 225 Innoviva shares in Q3 2025, an estimated $4.52K.
C.M. Bidwell & Associates first reported a position in Innoviva in Q2 2020 and held it in 12 quarters.
C.M. Bidwell & Associates's Innoviva position peaked at $119K in Q3 2023.
264 funds tracked by Wall St. Rank held Innoviva as of Q3 2025.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2025, filed 13 Nov 2025.